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The cellular uptake of the tricarboxylic acid cycle (TCA) intermediates is very important for cellular metabolism. However, the transport
pathways for these intermediates in liver cells are not well characterized. We have examined the transport of succinate and citrate in the human
hepatoma cell line Hep G2 and found that it exhibited a higher rate of succinate compared to citrate transport, which was sodium dependent.
Comparison of the transport properties of Hep G2 to that of human retinal pigment epithelial (HRPE) cells transfected with human sodium
dicarboxylate transporters, hNaDC-1, hNaDC-3, and hNaCT indicated that Hep G2 cells express a combination of hNaDC-3 and hNaCT. Short
period activation of protein kinase C (PKC) by phorbol 12-myristate, 13-acetate (PMA) and α-adrenergic receptor agonist, phenylephrine (PE),
downregulated sodium-dependent succinate transport presumably via hNaDC-3. The inhibition by PMAwas partially prevented by cytochalasin D,
suggesting that PKC reduces the hNaDC-3 activity, at least in part, by increased endocytosis. In contrast, activation of PKA by both forskolin and
epidermal growth factor (EGF) had no effect on succinate transport. Our results suggest that Hep G2 cells provide a useful model for studies of di-
and tricarboxylate regulation of human liver.
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Numerous studies have reported that the cellular uptake of
the tricarboxylic acid cycle (TCA) intermediates, di- and tricar-
boxylates, is very important for cellular metabolism. They are
not only intermediates in the TCA cycle for biological energy
production, but also are a source of cytosolic acetyl CoA for
the synthesis of fatty acids, isoprenoids, cholesterol, and for
the elongation of fatty acids [1–3]. The mammalian liver is
of physiologic importance for the synthesis of fatty acids,
isoprenoids, and cholesterol as well as glucose homeostasis,
biochemical pathways in which TCA cycle intermediates
have critical roles. These intermediates are mainly transported
into the cells by sodium-dicarboxylate cotransporters
(NaDCs) and the transport processes are classified into the
low- and high-affinity transporters based on substrate affinity.
The low-affinity sodium dicarboxylate transporter-1 (NaDC-1)
prefers succinate as a substrate with a Km value of 0.9 mM⁎ Corresponding author. Tel.: +66 2 2015614; fax: +66 2 354 7154.
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rabbit and human renal proximal tubule and intestine [4–6]. The
high-affinity sodium dicarboxylate transporter-3 (NaDC-3) is
found widely expressed in placenta, brain, liver, kidney, and
pancreas of human and rat, with a Km value for succinate in the
range of 20–102μM[7–9]. Recently, a sodium citrate transporter
(NaCT) has been cloned from rat brain [1] and was found to
accept citrate as the most preferred substrate.
The intermediates of TCA cycle have been reported to
be transported in the liver cells by both sodium-dependent
and -independent transport systems [10–16]. Studies using
isolated, perfused rat liver have shown that hepatic uptake of
dicarboxylates, such as α-ketoglutarate and malate, is localized in
perivenous hepatocytes [12–14]. Purified plasma membrane
vesicles from rat liver contain an electrogenic sodium-dependent
transport system for succinate and other dicarboxylates that
closely resembles the high-affinity NaDC-3 transporter from the
renal basolateral membrane [11,15,16]. Sodium-independent
transport of α-ketoglutarate has also been reported in basolateral
membrane from rat liver [10]. At present, citrate transport in liver
cells has not been characterized.
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display morphological and functional features of normal
hepatocyte cells, including synthesis of major plasma proteins
and expression of organic solute transporters [17–19]. These cells
provide a useful model system with which to study the regulation
of transporters for TCA cycle intermediates. The purpose of the
present study was to examine the transport pathways for both
succinate and citrate in Hep G2 cell line. The characteristics of
succinate and citrate transport found in Hep G2 cells were
compared with those of human retinal pigment epithelial (HRPE)
cells transiently transfected with human sodium dicarboxylate
transporters, hNaDC-1, hNaDC-3, and hNaCT. The main finding
is that the transport of succinate and citrate in Hep G2 cells is
mediated by a combination of two members of the SLC13 gene
family, the human high-affinity sodium dicarboxylate cotran-
sporter, hNaDC-3, and the human sodium citrate cotransporter,
hNaCT. The characteristics of succinate and citrate transport
found in Hep G2 were consistent with those of succinate and
citrate transport described for the hNaDC-3, and hNaCT
expressed in HRPE cells. RT-PCR analysis verified the presence
of hNaDC-3 and hNaCT transcripts in HepG2 cells. Furthermore,
kinetic analysis in Hep G2 cells revealed a high-affinity succinate
transport consistent with hNaDC-3. Finally, the regulation of
sodium-dependent succinate transport by PKC and PKA were
evaluated. Our experimental data clearly indicated that the Hep
G2 cells represent an excellent cell model system for further
studies on the regulatory mechanisms of endogenous di- and
tricarboxylate transporters.Table 1
Oligonucleotides used in RT-PCR reactions
Gene
(predicted
size, bp)
Genbank
accession
number
Sequence (sense and antisense strand)
hNaDC-1
(581)
U26209 5′-CCC TTA ATC CTG TTC CCT ATG A-3′
5′-TGG GGG AAG AGC GAG TTG A-3′
hNaDC-3
(750)
AF154121 5′-CAC CGC CTC CAC TGC CAT GAT GC-3′
5′-GAC GGG AAG AAG AAC AAG ATG GTG-3′
hNaCT
(647)
Y151833 5′-GGA GCT GCC AGG GAG TCA AGT G-3′
5′-GGA GGG GGATAA AAT GGA GTT TTC-3′2. Methods
2.1. Culture of Hep G2 cell line
Hep G2 cells, a human hepatoblastoma carcinoma cell line (The American
Type Culture Collection, Manassas, VA) were cultured in DMEM (Hyclone)
containing 10% heat-inactivated fetal bovine serum (Hyclone) and 1%
penicillin/streptomycin (Hyclone). Cell monolayers were maintained in a
humidified incubator at 37 °C and 5% CO2. Hep G2 cells were plated in 24-well
cell culture plates (Corning Inc.) at a density of 3.0×105 cells/well until they
reached confluence, approximately within 4 days.
2.2. Functional expression in HRPE cells
Human retinal pigment epithelial (HRPE) cells (Coriell Institute) were
transiently transfected with plasmids containing cDNA coding for hNaDC-1
[6,20], hNaDC-3 [9], and hNaCT [2] in pcDNA3.1 vector. They all are kindly
provided by Professor Ana M. Pajor (University of Texas Medical Branch,
Galveston, Texas). HRPE cells were cultured inModified Eagle's medium (Gibco/
BRL) supplemented with 10% heat-inactivated fetal bovine serum and 1%
penicillin/streptomycin. Prior to transfection, cells were plated at 1.2×105 cells/
well in 24-well plastic plates. When cell monolayers reached 50–80% confluence,
approximately 24 h after plating, cells in each well were transfected with 1.8 μg of
FuGENE6 (RocheDiagnostics Corp., Indianapolis, IN) and 0.6μg of recombinant
plasmid DNA. The cells were incubated for 48 h before measurement of transport
activity. Background counts in control cells transfected with pcDNA 3.1 vector
were subtracted from counts in experimental cDNA-transfected cells.
2.3. Transport assay
Transport of radiolabeled [14C]-succinate (specific activity 44 Ci/mol,
Moravek Biochemicals, Inc.) and [14C]-citrate (specific activity 107 Ci/mol,Amersham Biosciences) were measured at a final concentration of 10 μM. The
sodium-dependent transport buffer contained (in mM): NaCl (120), KCl (5),
MgSO4 (1.2), CaCl2 (1.2), D-glucose (5), and HEPES (25), pH adjusted to 7.4
with 1 M Tris. In sodium-free transport buffer, NaCl was substituted by 120 mM
choline chloride. Uptake experiments were performed at 37 °C. Cell monolayers
were first washed twice with prewarmed sodium-free transport buffer to remove
the medium. The transport reaction was started by the addition of 0.20 ml of
transport buffer containing [14C]-substrate and the cells were incubated for
10 min. The transport buffer containing [14C]-substrate was then aspirated off to
terminate the uptake and the cells were washed four times with 1 ml of transport
buffer without the radiolabeled substrate. Cell monolayers were then solubilized
with 0.20 ml of 20% sodium dodecyl sulfate (SDS) and 0.20 ml of the super-
natant were transferred to scintillation vials for liquid scintillation counting.
The transport of [14C]-succinate and [14C]-citrate in transfected HRPE cells
were measured essentially as described for Hep G2 cells. Uptake into HRPE
cells transfected with vector alone was subtracted from cDNA-containing plas-
mid transfected cells. Before adding radioactive uptake solution, HRPE cells
were preincubated for 15 min at room temperature with sodium-containing
transport buffer, which help to reduce background counts obtained in these
transfected cells.
2.4. RT-PCR
Hep G2 cells were cultured in T-75 plastic flasks (Corning Incorporated,
NY) and resuspended using 0.25% trypsin-EDTA. Total RNA isolation was then
performed using RNeasy Mini kit (QIAGEN) according to manufacturer's
instructions. Reverse transcription and PCR were carried out using one-step RT-
PCR kit (QIAGEN). The specific primers (BSU Bioservice unit, NSTDA,
Thailand) for hNaDC-1, hNaDC-3, and hNaCT are shown in Table 1. The
following reaction cycle was used for the RT-PCR : 50 °C for 30 min, 95 °C for
15 min, 40–45 cycles of 94 °C for 30 s, 56 °C for 45 s, and 72 °C for 60 s, then
followed by a 10-min final extension at 72 °C. The quality of the cDNA were
assessed by amplification of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (BSU Bioservice unit, NSTDA, Thailand), using the primers 5′-
TGA AGG TCG GAG TCA ACG GAT TTG GT-3′ and 5′-CAT GTG GGC
CAT GAG GTC CAC CAC-3′. PCR products were separated by electrophoresis
in 2% agarose gels and visualized by staining with ethidium bromide.
2.5. Na/K-ATPase activity assay
The protocol for cell permeabilization by alamethicin and assay of Na/K-
ATPase activity followed the methods of Woolcock and Specht, with some
modifications [21]. Briefly, Hep G2 cells were grown in 75 cm2 tissue culture
flasks. After they reached confluence, cells were detached by incubating with
0.25% trypsin-EDTA for 3 min. After centrifugation at 250×g for 5 min at 25 °C,
cells were then resuspended in warm buffer containing (in mM): HEPES (20) pH
7.4, NaCl (132), KCl (5), MgCl2 (1.5), CaCl2 (0.55), glucose (24.5), and 0.2 mg/
ml alamethicin [22] and incubated at 37 °C for 20 min. For phorbol 12-
myristate, 13-acetate (PMA) treated group, 100 nM PMA dissolved in DMSO
were added to cell suspension and preincubated at 37 °C for 20 min prior to
incubating with alamethicin for 20 min. Cells were then cooled briefly in ice
prior to Na/K-ATPase activity assay.
Fig. 1. (A–B) Uptake of succinate and citrate in (A) Hep G2 cells and (B) HRPE
cells transfected with hNaDC-1, hNaDC-3, and hNaCT. Uptake in Hep G2 of
10 μM [14C]-succinate or [14C]-citrate was measured in buffer containing either
NaCl or choline chloride after an incubation period of 10 min. Sodium-
dependent transport was calculated from the difference between uptake in NaCl
and choline chloride. Transport in HRPE cells was measured in NaCl buffer.
Data shown are mean±S.E.M., n=4 for Hep G2 cells, n=5 for hNaDC-1, n=3
for hNaDC-3, and n=4 for hNaCT.
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was added, and maintained on ice. The final composition of Na/K-ATPase
reaction mixture in mM, was as follows : HEPES (41) pH 7.4, histidine (40),
ATP (5), NaCl (132), KCl (22.5), MgCl2 (3.5), CaCl2 (0.55), and alamethicin
200 μg/ml. Another set of the assay sample contained 5 mM ouabain. The assay
was initiated by placing the plate at 37 °C, with agitation for 30 min, and then
placing onto ice. For cells treated with ouabain, the assay was initiated by
incubating cells at 37 °C, with agitation for 10 min prior to incubating with ATP.
Cells were then lysed with 600 μl of ice cold 0.2 M NaOH, and inorganic
phosphate liberated was measured by the method of Carter and Karl [23], using
KH2PO4 as standard. Protein concentration was determined by the method of
Lowry et al. [24] using bovine serum albumin as standard. Na/K-ATPase activity
was calculated as the difference in inorganic phosphate liberated in the presence
and absence of 5 mM ouabain, and expressed as μmol Pi/mg protein/h.
2.6. Kinetics analysis
The kinetics of succinate transport in Hep G2 cells were determined by
measuring the rate of succinate uptake at varying concentrations of succinate in
sodium-containing buffer while the concentration of radiolabeled succinate was
kept constant at 10 μM. The kinetics of uptake were examined in the form of the
Michaelis–Menten equation using Sigma Plot program (SYSTAT Software
Inc.):
V ¼ Vmax½S
Kmþ ½S
The kinetic constants (Michaelis constant, Km and maximal velocity, Vmax)
were calculated by using non-linear as well as linear regression methods. V is the
rate of substrate transport at concentration equal to [S]. Eadie–Hofstee trans-
formation (V versus V/S) of the same data was also performed.
2.7. Data analysis
All uptake measurements were performed with at least three independent
experiments. Data are shown as means±S.E.M. Significant differences from
control values were assessed using Student's t-test or one-way ANOVA for
multiple comparisons. Significance was accepted at p<0.05.
3. Results
3.1. Succinate and citrate transport
First, we examined the time-dependent uptake of [14C]-
succinate and [14C]-citrate into Hep G2 cells. They were
linear for at least 15 min. Therefore, all uptake studies were
performed with a 10-min incubation period. The uptake
assays were done using 10 μM substrate. Succinate and
citrate transport in Hep G2 cells were measured in both
sodium and choline buffer to compare the rates of sodium-
dependent and-independent transport, respectively. As shown
in Fig. 1A, Hep G2 cells predominantly transported succinate
in a sodium-dependent manner. The sodium-independent
transport of succinate was approximately 9% of the total.
Transport of citrate (1.08±0.15 pmol/well-min) in Hep G2
cells was much lower than that of succinate (11.22±1.15
pmol/well-min) with the sodium-independent transport being
14% of the total.
The sodium/dicarboxylate transporters from the SLC13
gene family carry both succinate and citrate, but with
different affinities. Therefore, we compared the transport of
succinate and citrate for hNaDC-1, hNaDC-3, and hNaCT
transiently expressed in HRPE cells. As shown in Fig. 1B,the rate of succinate transport by hNaDC-3 (2.48±0.26
pmol/well-min) was much higher than that of hNaDC-1
(0.48±0.06 pmol/well-min), and both hNaDC-1 and hNaDC-
3 had very low rates of citrate transport compare to that of
succinate. Human NaCT is predominantly a citrate transpor-
ter, although it also transports succinate approximately 50%
that of citrate. The differences in transport rates could reflect
the differences in Km for substrates. The hNaDC-3 had a
Km for succinate of about 20 μM, compared with 0.9 mM
in hNaDC-1 and approximately 2 mM in hNaCT [3,9,20].
The Km for citrate in hNaDC-1 was about 7 mM and
0.6 mM in hNaCT [3,20]. The Km for citrate in hNaDC-3
has not been reported although the rat NaDC-3 had a Km
for citrate of 220 μM [8].
Fig. 3. (A–C) RT-PCR analysis of sodium-dicarboxylate cotransporters
expressed in Hep G2 cells. RT-PCR reactions were carried out as described in
Methods. Gene specific primer pairs were used to amplify (A) hNaDC-1 (B)
hNaDC-3 and (C) hNaCT. Position of size standards (in bp) is shown in the first
lane and results of negative control reactions using water instead of cDNA is in
the second lane. Amplification of GAPDH was employed as internal control for
quality of cDNA produced. Arrows show the expected size of products.
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expressed as a ratio, the transport of succinate relative to
citrate in Hep G2 cells was 12:1 (Fig. 2). However, ratios of
transport of succinate relative to citrate in both hNaDC-1- and
hNaDC-3-transfected HRPE cells were approximately 24:1
and 22:1, respectively and that for NaCT was 0.4:1. A higher
succinate:citrate transport ratio would be expected in Hep G2
cells if only NaDC-1 and/or NaDC-3 were present. The lower
ratio indicates that NaCT also contributes to enhancing
transport of citrate in Hep G2 cells.
3.2. RT-PCR analysis of NaDCs expression
RT-PCRs were performed to determine the nature of NaDCs
expression in Hep G2 cells. Although our PCR analysis was
not aimed to be quantitative, we obtained the expression of
hNaDC-3 and hNaCT transcripts, which is consistent with the
transport activities in Hep G2 cells (Fig. 3). We also found
very low level of hNaDC-1 transcript.
3.3. Effects of lithium on succinate and citrate transport
Lithium at millimolar concentrations has been shown to
inhibit or activate the sodium-dicarboxylate cotransporters from
the SLC 13 gene family [2,7,9,20]. Therefore, we tested the
effect of 2.5, 10, and 30 mM lithium on sodium-dependent
succinate and citrate transport in Hep G2 cells and compared the
results with that of HRPE cells transfected with hNaDC-3 and
hNaCT. As shown in Fig. 4A, lithium (2.5–30 mM) inhibited
succinate transport and stimulated citrate transport in Hep G2
cells in a dose-dependent manner. As shown in Fig. 4B, both
succinate and citrate transport by hNaDC-3 expressed in HRPE
cells were inhibited by lithium, with a stronger effect on citrate
transport. In contrast, both succinate and citrate transport by
hNaCT expressed in HRPE cells were stimulated by lithium ;
approximately 4-fold and 3.3-fold greater than control,
respectively.Fig. 2. Ratio of sodium-dependent succinate to citrate transport of Hep G2 cells
and HRPE cells transiently expressing hNaDC-1, hNaDC-3, and hNaCT. Data
are from Fig. 1.3.4. Effects of adipate on succinate and citrate transport
High- and low-affinity sodium-dicarboxylate transporters
differ in their ability to handle dicarboxylates with more than
four carbon atoms, such as glutarate (5 carbons) and adipate (6
carbons). The low-affinity transporter, NaDC-1, prefers four
carbon dicarboxylates such as succinate but has a very low affinity
for glutarate [20], whereas dicarboxylates of four- and five-carbon
chain length are the ideal substrates for NaDC-3 [9] and citrate (5
carbons) is the most preferred substrate for hNaCT [2]. We tested
the effect of adipate on sodium-dependent transport of succinate
and citrate in Hep G2 cells compared with HRPE cells expressing
hNaDC-3 and hNaCT. In Hep G2 cells, adipate inhibited
succinate transport by about 60% but had no effect on citrate
transport (Fig. 5A). In HRPE cells expressing hNaDC-3, the
transport of both succinate and citrate were greatly inhibited by
adipate, whereas transport of HRPE cells expressing hNaCTwas
insensitive to adipate (Fig. 5B).
3.5. Effect of protein kinase C activation by phorbol
12-myristate, 13-acetate (PMA) on succinate uptake
It is noted that Hep G2 cells express more robust NaDC-3
activity than NaCT activity. Therefore, we chose to study the
regulatory mechanism of NaDC-3 in this cell line. We first
Fig. 5. (A–B) Effect of adipate on sodium-dependent succinate and citrate
transport in (A) Hep G2 cells and (B) in HRPE cells transfected with cDNA
coding for hNaDC-3 and hNaCT. Uptake of 10 μM [14C]-succinate or [14C]-
citrate in Hep G2 cells were measured after an incubation of 10 min in buffer
containing either NaCl or choline chloride in the absence and presence of 1 mM
adipate. Sodium-dependent transport was calculated from the difference between
uptake in NaCl and choline chloride. Transport in HRPE cells was measured in
NaCl buffer in the absence and presence of 1 mM adipate. The data are expressed
as a percentage of the control. Mean value for succinate and citrate transport in
control Hep G2 cells was 10.39±1.17 pmol/well-min and 0.93±0.14 pmol/
well-min, respectively. Mean value of succinate and citrate transport in control
hNaDC-3-transfected HRPE cells was 2.48±0.26 pmol/well-min and 0.11±0.01
pmol/well-min, respectively, and mean value of succinate and citrate transport in
control hNaCT-transfected HRPE cells was 0.23±0.02 pmol/well-min and
0.54±0.02 pmol/well-min. The dotted line indicates the position of 100%
activity. Data are mean±S.E.M., n=4 for Hep G2 cells, n=5 for hNaDC-1,
n=3 for hNaDC-3, and n=4 for hNaCT. * denotes significant difference from
control, p<0.05.
Fig. 4. (A–B) Effect of lithium on sodium-dependent succinate and citrate
transport in (A) Hep G2 cells and (B) HRPE cells transfected with hNaDC-3, and
hNaCT. Uptake in Hep G2 cells of 10 μM [14C]-succinate or [14C]-citrate was
measured after an incubation period of 10 min in buffer containing either NaCl or
choline chloride in the absence and presence of LiCl. Sodium-dependent
transport was calculated from the difference between uptake in NaCl and choline
chloride. Transport in HRPE cells was measured in NaCl buffer in the absence
and presence of LiCl. Uptakes are expressed as percent of control.Mean value for
succinate and citrate transport in control Hep G2 cells was 10.39±1.17 pmol/
well-min and 0.93±0.14 pmol/well-min, respectively. Mean value of succinate
and citrate transport in control hNaDC-3-transfected HRPE cells was 2.48±0.26
pmol/well-min and 0.11±0.01 pmol/well-min, respectively, and mean value of
succinate and citrate transport in control hNaCT-transfected HRPE cells was
0.23±0.02 pmol/well-min and 0.54±0.02 pmol/well-min. respectively. The
dotted line indicates the position of 100%. Data shown are mean±S.E.M, n=4
for Hep G2 cells, n=5 for hNaDC-1, n=3 for hNaDC-3, and n=4 for hNaCT.
* denotes significant difference from control, p<0.05.
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NaDC-3-mediated succinate uptake in Hep G2 cells. Sodium-
dependent succinate uptake was examined using both a PKC
activator, phorbol 12-myristate, 13-acetate (PMA), and an
inhibitor, bisindoylmaleimide I (BIM). As shown in Fig. 6A,
Fig. 6. (A) Effect of PMA and BIM on rate of [14C] sodium-dependent succinate
uptake in Hep G2 cells. Uptake of 10 μM [14C]-succinate was measured after an
incubation period of 10 min in buffer containing either NaCl or choline chloride.
Sodium-dependent transport was calculated from the difference between uptake
inNaCl and choline chloride. The concentrations of PMAandBIMwere 100 nM.
For PMA or BIM treatment, cells were preincubated for 25 min. For PMA plus
BIM, cells were first preincubated for 5 min in buffer containing 100 nM BIM,
followed by 25 min in buffer containing both PMA and BIM, and followed by a
10-min incubation in PMA- and BIM-free buffer containing [14C]-succinate.
Data shown are mean±S.E.M of three samples. Mean control value for succinate
transport was 10.23±0.07 pmol/well-min. * and # denote significant difference
(p<0.05) from control and PMA-treated group respectively. (B) Effect of PE and
BIM on rate of [14C] sodium-dependent succinate uptake in Hep G2 cells. The
preincubation protocol was that used with PMA and BIM. The concentrations of
PE and BIM were 1 μM and 100 nM respectively. Data shown are mean±S.E.M
of six samples.Mean control value for succinate transport was 10.82±0.07 pmol/
well-min. * and # denote significant difference (p<0.05) from control and PE-
treated group respectively.
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about 60% inhibition of succinate transport. To determine
whether the inhibitory effect produced by PMA on succinatetransport of Hep G2 cells reflected activation of PKC, we also
examined the effect of preincubating Hep G2 cells with 100 nM
BIM, which showed no effect on sodium-dependent succinate
uptake (Fig. 6A). When the cells were first preincubated with
BIM alone and then the medium was changed to the one con-
taining PMA plus BIM, the inhibitory effect of PMA in the
presence of BIM was significantly less than that of PMA alone.
3.6. Effect of PKC activation by phenylephrine (PE) on
succinate uptake
To determine whether the regulatory action of PKC on
NaDC-3-mediated succinate uptake in Hep G2 cells was
indirectly mediated via ligand-coupled physiological receptor,
succinate uptake was examined using phenylephrine (PE) which
is known to activate PKC via an α-adrenergic receptor [25]. As
shown in Fig. 6B, preincubation of HepG2 cells with PE at 1μM
resulted in approximately 55% inhibition of sodium-dependent
succinate transport. Similar to the experiment with PMA, the
inhibitory effect of PE on succinate uptake in the presence of
BIM was significantly less than that of PE alone.
3.7. Effects of colchicine and cytochalasin D on PMA-induced
inhibition of succinate uptake
To determine whether the inhibitory effect of PMA on
sodium-dependent succinate transport in Hep G2 cells involved
protein trafficking related to the insertion or deletion of cell
surface transporters, colchicine, which disrupts microtubule
polymerization [26,27], and cytochalasin D, which disrupts
actin microfilaments [27,28] were tested. Hep G2 cells were
preincubated in buffer containing 20 μM colchicine for 1 h or
20 μM cytochalasin D for 20 min [29,30] at 37 °C alone or prior
to the treatment with PMA. As shown in Fig. 7, colchicine could
not prevent an inhibition of sodium-dependent succinate
transport by PMA. In contrast, cytochalasin D could prevent the
inhibitory effect of PMA on sodium-dependent succinate
transport. In the absence of PMA, neither colchicine nor
cytochalasin D influenced sodium-dependent succinate transport.
3.8. Kinetics of succinate transport
Kinetic analysis of succinate transport presumably via
hNaDC-3 in Hep G2 cells was performed to verify its affinity.
In addition, the effect of PKC on the kinetic parameters of
succinate uptake was also examined. The Km and Vmax of
succinate transport rate was obtained with Km of 95.43±
34.37 μM and Vmax of 77.09±27.11 pmol/well-min (Fig. 8A).
Upon activation of PKC by 100 nM PMA, both Km and Vmax
of succinate transport rate in Hep G2 cells were decreased to
28.17±0.84 μM and 47.58±4.73 pmol/well-min, respectively
(Fig. 8B).
3.9. Effect of PMA on Na/K-ATPase activity
It was shown that the activity of Na/K-ATPase in various cell
types, such as SH-SY5Y human neuroblastoma cells and green
Fig. 7. Effects of colchicine and cytochalasin D on PMA-induced inhibition of
sodium-dependent [14C]-succinate uptake in Hep G2 cells. Uptake of 10 μM
[14C]-succinate was measured after an incubation period of 10 min in buffer
containing either NaCl or choline chloride. Sodium-dependent transport was
calculated from the difference between uptake in NaCl and choline chloride.
Hep G2 cells were preincubated with buffer containing 20 μM colchicine for
1 h or 20 μM cytochalasin D for 20 min at 37 °C. After incubation, the
solutions were removed followed by three washes with choline buffer and
were then incubated with 100 nM PMA for 25 min. Cells were then incubated
for 10 min with buffer containing [14C]-succinate to measure succinate uptake.
Data shown are mean±S.E.M of three samples for colchicine treated group and
of six samples for cytochalasin D treated group. * denotes a significant
difference (p<0.05), between PMA treatment in the presence and absence of
cytochalasin D.
Fig. 8. (A) Kinetics of sodium-dependent [14C] succinate transport in Hep G2
cells. Uptake was measured after an incubation period of 10 min in buffer
containing either NaCl or choline chloride. Sodium-dependent transport was
calculated from the difference between uptake in NaCl and choline chloride. The
transport uptake was carried out as described in Methods. Each data point
represents the mean±S.E.M. of 3 samples. (B) Effect of PMA on the kinetics of
sodium-dependent [14C] succinate transport in Hep G2 cells. PMA at 100 nM
was preincubated for 25 min, followed by a 10-min incubation in PMA free-
buffer containing [14C]-succinate. Each data point represents the mean±S.E.M.
of 3 samples. Inset : Eadie–Hofstee transformation of the same data. V, uptake
rate in pmol/well-min; S, substrate concentration in mM; and V/S is calculated
from substrate concentration in micromolar.
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kinases [21,31]. Activation of PKC inhibited sodium-dependent
succinate uptake via hNaDC-3 in Hep G2 cells (Fig. 6A). To test
this possibility we investigated whether PKC can modulate Na/
K-ATPase in our system. Determination of ouabain-sensitive
inorganic phosphate released showed that the activity of Na/K-
ATPase in HepG2 cells without PMA treatment was 790±
11 nmol/mg protein/h. Following incubation with 100 nM PMA
for 25 min, Na/K-ATPase activity was not changed (781±
15 nmol/mg protein/h).
3.10. Effect of forskolin and epidermal growth factor (EGF) on
succinate uptake
In addition to PKC, PKA has been shown to play a role in
modulating several membrane transport activities [32,33]. To
further determine this possible regulatory action of PKA on
NaDC-3-mediated succinate uptake in Hep G2 cells, a potent
activator of adenylate cyclase (AC), forskolin that has been
extensively used to increase intracellular cAMP level and to
elicit cAMP-dependent PKA activation [34], was tested. In
addition, the effect of EGF that has been shown to activate PKA
via mitogen-activated protein kinase (MAPK) pathway was also
examined [34]. As shown in Fig. 9, preincubation of Hep G2
cells with either 10 μM forskolin or 10 ng/ml EGF for 10 min
had no effect on sodium-dependent succinate transport.4. Discussion
The present study was conducted to examine the transport
pathways for succinate and citrate in a human hepatoblastoma
carcinoma cell line, Hep G2 that retains many characteristics of
normal liver cells [17–19]. The regulatory mechanisms of the
predominate transporter, NaDC-3, in Hep G2 cells were also
examined. TCA cycle intermediates are not only important for
energy production but also are a source of acetyl CoA that
enters cholesterol and lipid biosynthetic pathways [35]. Intra-
cellular levels of citrate also regulate the activities of enzymes
involved in fatty acid biosynthesis and degradation [35]. Clearly
further study is needed to understand the relationship between
Fig. 9. Effect of forskolin and EGF on rate of [14C] sodium-dependent succinate
uptake in Hep G2 cells. Uptake of 10 μM [14C]-succinate was measured after an
incubation period of 10 min in buffer containing either NaCl or choline chloride.
Sodium-dependent transport was calculated from the difference between uptake
in NaCl and choline chloride. The concentrations of forskolin and EGF cells
were 10 μM and cells were preincubated for 10 min, followed by a 10-min
incubation in forskolin- or EGF-free buffer containing [14C]-succinate. Data
shown are mean±S.E.M of three experiments. Mean control value for succinate
transport was 10.05±0.9 pmol/well-min.
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cholesterol and lipid metabolism. It is possible that the
transporters for TCA cycle intermediates in liver cells may be
a potential therapeutic target for controlling cholesterol and
lipid metabolism in this organ.
We found that the transport pathways for succinate and citrate
in Hep G2 cells were predominantly sodium-dependent and were
likely to be mediated by a combination of hNaDC-3 and hNaCT.
Accordingly, RT-PCR results showed that hNaDC-3 and hNaCT,
but not hNaDC-1 genes were transcribed in Hep G2 cells.
Succinate transport was greater than that of citrate inHepG2 cells,
it is likely that NaDC-3 activity predominates in these cells.
Succinate transport is probably mediated mostly by NaDC-3, as
indicated by the inhibition of succinate transport by NaDC-3
inhibitors, lithium and adipate. Citrate transport in Hep G2 cells is
probably mediated primarily by NaCT, consistent with a
stimulation of citrate transport by lithium and lack of inhibitory
effect by adipate.
In addition, the affinity for sodium-dependent succinate
transport in Hep G2 cells from kinetic studies suggests that
hNaDC-3 mediates the high-affinity transport. The Km for
succinate obtained in the present study was 95.43±34.37 μM
(Fig. 8A), consistent with the previous value of 20 μM for the
high-affinity hNaDC-3 transporter expressed in HRPE cells, and
about 102 μM in oocyte expressing human placenta NaDC-3
system [9]; and ∼25 μM in oocytes expressing human kidney
NaDC-3 [7]. On the other hand, the Km for succinate was
found to be 0.9 mM for hNaDC-1 expressed in oocytes [20]
and approximately 2 mM for hNaCT transfected in HRPE
cells [2].Given the significant functional roles of sodium-dependent
dicarboxylate transporters in Hep G2 cells, it is important to
understand how they are regulated. Although regulation of
sodium-dependent NaDC transporters can be examined with
cloned transporters expressed in transfected cell systems, it is
essential to study the regulatory responses of these processes
expressed in their native, intact cells. Previous studies have
shown that rat NaDC-1 exhibits adaptive changes to protein
abundance and in response to chronic metabolic acidosis and
potassium depletion [36]. Besides these studies on chronic
effects on sodium-dependent dicarboxylate transporters, acute
regulation of hNaDC-1 and winter flounder NaDC-3 (fNaDC-3)
have also been studied [37,38]. It has been reported that NaDC-1
transport activity is markedly inhibited by activators of PKC due
to a combination of microtubule-dependent endocytosis of
NaDC-1 from the plasma membrane and a direct inhibition of
transport activity [38]. The transport activity of fNaDC-3 is also
reduced by the PKC activator, PMA, through endocytosis and
downregulation of transporter by PKC [37]. However, the acute
regulation of hNaDC-3 has not hitherto been studied.
In the present study, we emphasized the investigation of the
effect of PKCon sodium-dependent succinate transport (NaDC-3)
due to its high activity in Hep G2 cells. As shown in Fig. 6A, a
marked inhibition of succinate transport was seen when Hep G2
cells were exposed to PMA. The inhibitory effect was partially
antagonized by BIM, a PKC inhibitor. Exposure to BIM alone,
however, had no significant effect on sodium-dependent succinate
uptake, implying that under basal physiological conditions,
succinate transport activity of hNaDC-3 of Hep G2 cells is not
under the tonic influence of PKC.We also investigated the indirect
activation of PKC through physiological ligand, α1-adrenergic
receptor agonist phenylephrine (PE). As shown in Fig. 6B, PE also
inhibited sodium-dependent succinate uptake. This inhibition was
also partially antagonized by BIM. Although BIM did not
completely abolish the inhibitory effect of PMA or PE on
hNaDC-3 activity, the significant reduction of succinate transport
following exposure to BIM supports the conclusion that
activation of PKC exerts a regulatory influence on succinate
transport mediated by hNaDC-3. The inability to completely
antagonize the effect of PMA or PE by BIM may have been due
to suboptimal concentration of BIM used in this study (100 nM)
as 50% inhibition of BIM is 200–250 nM [39]. A BIM
concentration greater than 100 nM was not employed due to
possible nonspecific effects for PKC at high concentration [39].
PMA activates all isoforms of PKC, whereas BIM is most
effective at inhibiting PKC group A [40].
The inhibitory effect of PMA on sodium-dependent succinate
transport was associatedwith an increase in substrate affinity but a
decrease in maximal velocity as shown in Fig. 8B. A decrease in
maximal velocity was linked to a decrease in the functional
transporters in the plasmamembrane, suggesting that PKC affects
the number of transporters expressed on the cell membrane. The
present study found that the effect of PMA on succinate
transport was prevented by cytochalasin D, which acts by
disrupting actin microfilaments [27,28,30]. However, colchicine,
which has been shown to affect microtubule polymerization had
no effect on succinate transport by PMA (Fig. 7). Actin
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endocytosis of transporters from apical membranes of polarized
cells, such as in MDCK cells and in C6 glioma cells stably
expressing the high-affinity neurotensin receptor NTS1 [28,30],
while microtubule polymerization has been shown to affect
exocytosis of phosphate transporter in rat proximal tubule cells
[26]. Taken together, our results suggest that a decrease in
succinate transport activity by PMAmight be explained, at least in
part, by increased endocytosis. However, more direct methods
(e.g., immunofluorescence and cell membrane capacitance
measurements) are needed to verify this notion.
One would expect an increase in succinate uptake to occur in
parallel with an increase in its affinity to the transporter.
Surprisingly, an inverse relationship was observed between
succinate transport rate and substrate affinity after PKC
activation. We do not have an adequate explanation for this
observation. This finding is similar to that of Groves' study [41]
where substrate with high affinity for peritubular organic cation
transporter, tetrapentylammonium (TPeA), decreases the efflux
of tetraethylammonium (TEA) in rabbit proximal tubule,
suggesting that the turnover of carrier is slow when bound to
this compound compared with that of an empty or one bound to
TEA. Indeed, carrier turnover includes substrate binding,
translocation and dissociation [41]. We speculate that there
might be a second site not directly involved in translocation
where succinate binding following PKC activation produces
inhibition and/or slows down turnover rate of the transporter.
Another possible explanation could be that activation of PKC
with PMA changes the nature of an interaction of NaDC-3 with
an unidentified accessory protein which modulates its turnover
rate. In addition, the observed changes of the current study in the
kinetic parameters of succinate transport after exposure to PMA
might involve the phosphorylation of NaDC-3. Eight consensus
sequences for PKC-dependent phosphorylation in hNaDC-3
have been reported [9]. Even though the modulation of transport
activity of NaDC-1 and fNaDC-3 transiently transfected in
oocytes by PKC seems not to involve the PKC phosphorylation
sites [37,38], there may be different PKC isoforms expressed in
Hep G2 cells that are involved in the inhibitory mechanisms of
succinate transport of hNaDC-3 by PKC. Further studies are
necessary to identify such changes of the transporter.
As succinate uptake via hNaDC-3 involves the parallel activity
of Na/K-ATPase [9], modulation of Na/K-ATPase activity may
result in a change in succinate uptake activity of NaDC-3
transporter as well. In fact, both the inhibition and stimulation of
Na/K-ATPase activity have been reported in different cell lines
and tissues, and in different assay conditions [31]. There are
evidences showing that the activity of Na/K-ATPase can be
modulated by signaling pathways that involve the activation of
PKA and/or PKC [42]. Direct phosphorylation of Na/K-ATPase
by PKC has been demonstrated in intact cells and tissues [43–45].
It was shown that PKC activation also inhibits activity of rat Na/
K-ATPase isoforms expressed in Sf-9 insect cells, rat choroids
plexus, andOKcells [44–46]. Recent studies in human SH-SY5Y
cell line also reported that PKC inhibits Na/K-ATPase activity
[21]. In the current study, we found that PKC activator, PMA, at
the condition which inhibited sodium-dependent succinate uptakevia hNaDC-3 had no effect onNa/K-ATPase activity in intact Hep
G2 cells. Thus, it appears that the inhibitory effect of PMA on
sodium-dependent succinate transport activity reflects a direct
effect on the transporters. This is in part by reduction in the
number of transporters expressed on the plasma membrane via
endocytosis as discussed above.
It has been reported that hNaDC-3 also contains one site for
cAMP-dependent protein kinase phosphorylation in addition to
PKC-dependent protein kinase [9]. We investigated the influence
of PKA on the activity of hNaDC-3-mediated sodium-dependent
succinate transport in Hep G2 cells and found that, unlike the
effect of PKC, PKA stimulation by forskolin had no effect on
succinate uptake (Fig. 9). Previous studies have shown that EGF
stimulates the activities of many transporters via indirect
activation of PKA [47–49]. However, EGF had no effect on
succinate uptake in Hep G2 cells.
In summary, we have identified sodium-dependent and
sodium-independent transporters that mediate succinate and
citrate transport in Hep G2 cells. The predominant sodium-
dependent pathway for succinate transport in Hep G2 cells is
likely to be hNaDC-3, whereas citrate transport is mediated
primarily by hNaCT. Kinetic analysis of succinate uptake in Hep
G2 cells confirmed its high-affinity property consistent with that
of hNaDC-3. Moreover, the current study demonstrated that the
sodium-dependent succinate transport in Hep G2 cells was
downregulated by PKC but was not affected by PKA. PKC
inhibition of the activity of hNaDC-3 could be at least in part be
due to microtubule-dependent endocytosis of hNaDC-3 reducing
the number of transporter in the plasma membrane. These studies
indicate that Hep G2 cells could provide a physiologically
relevant cell model for further studies of regulation of endogenous
di- and tricarboxylate transporters.
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